Kashi Clinical Laboratories offers high-quality assay development for a wide variety of platforms and chemistries that support multiple specimen types. Our experienced research and development team develops all testing in-house, upon request, and it is tailored to your needs.
As a healthcare provider, is there a genetic test you would like to use in your practice, but that isn’t yet available on the market, or is cost-prohibitive? Contact Kashi to find out more about collaborations in testing development.
We combine rigorous analytical validation with the flexibility to customize assay parameters and reporting to best meet your needs. Custom assay designs are critical to providing accurate, sensitive, reproducible, efficient, and standardized molecular testing. At Kashi, our accomplished team applies rigorous scientific methods for rapid assay development and validation to not only meet, but exceed, current regulatory guidelines set by Clinical Laboratory Improvement Amendments (CLIA) and the College of American Pathologists.
The Kashi team uses a variety of molecular approaches tailored to your unique needs, including exome and custom targeted sequencing by Next Generation Sequencing and Sanger Sequencing, RT-PCR for gene expression and SNP genotyping, and capillary electrophoresis. Our commitment to quality biomarker detection extends throughout Kashi. We use the latest in technology, and our customer service is personal and timely.